Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GCS-100 + Etoposide + Dexamethasone in Relapsed/Refractory DLBCL
NCT00776802Phase 2Withdrawn
- Sponsor
- La Jolla Pharmaceutical Company
- Start
- Jul 2008
- Primary completion
- Apr 2009
- Modality
- Polysaccharide, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of GCS-100 in diffuse large B-cell lymphoma (DLBCL), sponsored by La Jolla Pharmaceutical Company. Planned start Jul 2008; status: withdrawn.
02
Drugs
GCS-100
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00776802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00776802.